Literature DB >> 22644809

Mesenchymal stromal cell phenotype is not influenced by confluence during culture expansion.

Mandana Haack-Sørensen1, Susanne Kofoed Hansen, Louise Hansen, Michael Gaster, Poul Hyttel, Annette Ekblond, Jens Kastrup.   

Abstract

BACKGROUND: Accumulating preclinical and clinical evidence indicates that human mesenchymal stromal cells (MSCs) are good candidates for cell therapy. For clinical applications of MSCs extensive in vitro expansion is required to obtain an adequate number of cells. It is evident that the pursuit for cell quantity must not affect quality, but it is also a fact that in vitro culture conditions affect MSC phenotype. One possible variable is the degree of cell confluence during expansion.
METHODS: We investigate the influence of cell density on homogeneity and differentiation during culture expansion of un-stimulated MSCs isolated from the bone marrow in DMEM and fetal bovine serum (FBS). MSC morphology, phenotype and differentiation were investigated weekly during 5 weeks culture expansion using electron microscopy, flow cytometry, immunocytochemistry, qualitative RT-PCR and quantitative Q-PCR.
RESULTS: The morphological observation and the phenotypic analyses showed that MSCs after 3 weeks cultivation constituted a phenotypically homogenous MSC cell population, which at low levels expressed genes for different cell lineages, confirming their multilineage plasticity, without actual differentiation. This phenotype persisted independent of increasing cell densities. DISCUSSION: These data demonstrate that MSC characteristics and plasticity can be maintained during culture expansion from bone marrow mononuclear cells to MSCs and that a homogeneous phenotype of undifferentiated MSCs which persists independent of cell density can be used for clinical therapies.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22644809     DOI: 10.1007/s12015-012-9386-3

Source DB:  PubMed          Journal:  Stem Cell Rev Rep        ISSN: 2629-3277            Impact factor:   5.739


  72 in total

1.  Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms.

Authors:  T Kinnaird; E Stabile; M S Burnett; C W Lee; S Barr; S Fuchs; S E Epstein
Journal:  Circ Res       Date:  2004-01-22       Impact factor: 17.367

2.  Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells.

Authors:  Massimiliano Gnecchi; Huamei He; Olin D Liang; Luis G Melo; Fulvio Morello; Hui Mu; Nicolas Noiseux; Lunan Zhang; Richard E Pratt; Joanne S Ingwall; Victor J Dzau
Journal:  Nat Med       Date:  2005-04       Impact factor: 53.440

3.  Serofendic acid, a neuroprotective substance derived from fetal calf serum, inhibits mitochondrial membrane depolarization and caspase-3 activation.

Authors:  Toshiaki Kume; Ryota Taguchi; Hiroshi Katsuki; Masaharu Akao; Hachiro Sugimoto; Shuji Kaneko; Akinori Akaike
Journal:  Eur J Pharmacol       Date:  2006-05-03       Impact factor: 4.432

4.  Extracellular matrix gene expression by human bone marrow stroma and by marrow fibroblasts.

Authors:  C O Chichester; M Fernández; J J Minguell
Journal:  Cell Adhes Commun       Date:  1993-09

5.  Serum free cultured bone marrow mesenchymal stem cells as a platform to characterize the effects of specific molecules.

Authors:  Leonardo Solmesky; Sharon Lefler; Jasmine Jacob-Hirsch; Shlomo Bulvik; Gideon Rechavi; Miguel Weil
Journal:  PLoS One       Date:  2010-09-10       Impact factor: 3.240

6.  Autologous in vitro expanded mesenchymal stem cell therapy for human old myocardial infarction.

Authors:  Mandana Mohyeddin-Bonab; Mohamad-Reza Mohamad-Hassani; Kamran Alimoghaddam; Mehdi Sanatkar; Masuod Gasemi; Hamid Mirkhani; Hassan Radmehr; Mehrdad Salehi; Massoud Eslami; Amir Farhig-Parsa; Hassan Emami-Razavi; Mahmood Gholam Alemohammad; Mahmood Ghasemi al-Mohamad; Ali-Akbar Solimani; Ardeshir Ghavamzadeh; Behrouz Nikbin
Journal:  Arch Iran Med       Date:  2007-10       Impact factor: 1.354

7.  Mesenchymal stromal cell and mononuclear cell therapy in heart disease.

Authors:  Mandana Haack-Sorensen; Tina Friis; Jens Kastrup
Journal:  Future Cardiol       Date:  2008-09

8.  Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation.

Authors:  Karin Tarte; Julien Gaillard; Jean-Jacques Lataillade; Loic Fouillard; Martine Becker; Hossein Mossafa; Andrei Tchirkov; Hélène Rouard; Catherine Henry; Marie Splingard; Joelle Dulong; Delphine Monnier; Patrick Gourmelon; Norbert-Claude Gorin; Luc Sensebé
Journal:  Blood       Date:  2009-12-23       Impact factor: 22.113

Review 9.  Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy.

Authors:  S P Bruder; D J Fink; A I Caplan
Journal:  J Cell Biochem       Date:  1994-11       Impact factor: 4.429

Review 10.  Immunomodulatory properties of mesenchymal stem cells: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005.

Authors:  Alan Tyndall; Ulrich A Walker; Andrew Cope; Francesco Dazzi; Cosimo De Bari; Willem Fibbe; Serena Guiducci; Simon Jones; Christian Jorgensen; Katarina Le Blanc; Frank Luyten; Dennis McGonagle; Ivan Martin; Chiara Bocelli-Tyndall; Giuseppina Pennesi; Vito Pistoia; Constantino Pitzalis; Antonio Uccelli; Nico Wulffraat; Marc Feldmann
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

View more
  9 in total

1.  Activation of Notch1 signalling promotes multi-lineage differentiation of c-Kit(POS)/NKX2.5(POS) bone marrow stem cells: implication in stem cell translational medicine.

Authors:  Ranran Ding; Xiaofan Jiang; Yanping Ha; Zhenliang Wang; Junli Guo; Hanguo Jiang; Shaojiang Zheng; Zhihua Shen; Wei Jie
Journal:  Stem Cell Res Ther       Date:  2015-05-09       Impact factor: 6.832

2.  Trophic actions of bone marrow-derived mesenchymal stromal cells for muscle repair/regeneration.

Authors:  Chiara Sassoli; Sandra Zecchi-Orlandini; Lucia Formigli
Journal:  Cells       Date:  2012-10-17       Impact factor: 6.600

3.  Comparative analysis of cardiovascular development related genes in stem cells isolated from deciduous pulp and adipose tissue.

Authors:  Zhang Xin Loo; Wijenthiran Kunasekaran; Vijayendran Govindasamy; Sabri Musa; Noor Hayaty Abu Kasim
Journal:  ScientificWorldJournal       Date:  2014-12-07

4.  Aggregation of Human Eyelid Adipose-derived Stem Cells by Human Body Fluids.

Authors:  Yeonhwa Song; Sujin Yun; Hye Jin Yang; A Young Yoon; Haekwon Kim
Journal:  Dev Reprod       Date:  2012-12

5.  The Impact of Confluence on Bone Marrow Mesenchymal Stem (BMMSC) Proliferation and Osteogenic Differentiation.

Authors:  Faten A M Abo-Aziza; Zaki A A
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2017-04-01

6.  In Vivo MRI Tracking of Mesenchymal Stromal Cells Labeled with Ultrasmall Paramagnetic Iron Oxide Particles after Intramyocardial Transplantation in Patients with Chronic Ischemic Heart Disease.

Authors:  Anders Bruun Mathiasen; Abbas Ali Qayyum; Erik Jørgensen; Steffen Helqvist; Annette Ekblond; Michael Ng; Kishore Bhakoo; Jens Kastrup
Journal:  Stem Cells Int       Date:  2019-11-14       Impact factor: 5.443

7.  Cell heterogeneity, rather than the cell storage solution, affects the behavior of mesenchymal stem cells in vitro and in vivo.

Authors:  Yong-Hong Wang; Ya-Chao Tao; Dong-Bo Wu; Meng-Lan Wang; Hong Tang; En-Qiang Chen
Journal:  Stem Cell Res Ther       Date:  2021-07-13       Impact factor: 6.832

8.  The Proportion of ALDEFLUOR-Positive Cancer Stem Cells Changes with Cell Culture Density Due to the Expression of Different ALDH Isoforms.

Authors:  Lynn M Opdenaker; Shirin R Modarai; Bruce M Boman
Journal:  Cancer Stud Mol Med       Date:  2015-12-09

Review 9.  Reparative and Regenerative Effects of Mesenchymal Stromal Cells-Promising Potential for Kidney Transplantation?

Authors:  Merel Pool; Henri Leuvenink; Cyril Moers
Journal:  Int J Mol Sci       Date:  2019-09-18       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.